RCG
IDXX icon

Ruane, Cunniff & Goldfarb’s Idexx Laboratories IDXX Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,146
Closed -$312K – 42
2019
Q3 		$312K Hold
1,146
– – ﹤0.01% 33
2019
Q2 		$316K Hold
1,146
– – ﹤0.01% 32
2019
Q1 		$256K Sell
1,146
-446
-28% -$92.1K ﹤0.01% 50
2018
Q4 		$296K Hold
1,592
– – ﹤0.01% 54
2018
Q3 		$397K Sell
1,592
-197
-11% -$47.8K ﹤0.01% 56
2018
Q2 		$390K Buy
1,789
+446
+33% +$91.9K ﹤0.01% 59
2018
Q1 		$254K Sell
1,343
-1,022
-43% -$189K ﹤0.01% 57
2017
Q4 		$370K Sell
2,365
-554
-19% -$87.2K ﹤0.01% 61
2017
Q3 		$454K Sell
2,919
-446
-13% -$70.5K ﹤0.01% 67
2017
Q2 		$543K Sell
3,365
-21,253
-86% -$3.45M 0.01% 65
2017
Q1 		$3.81M Sell
24,618
-3,123
-11% -$430K 0.04% 58
2016
Q4 		$3.25M Sell
27,741
-79,203
-74% -$9.04M 0.03% 59
2016
Q3 		$12.1M Sell
106,944
-950
-0.9% -$100K 0.11% 44
2016
Q2 		$10M Sell
107,894
-7,560,282
-99% -$649M 0.1% 45
2016
Q1 		$601M Sell
7,668,176
-359,192
-4% -$25.9M 4.67% 7
2015
Q4 		$585M Sell
8,027,368
-139,906
-2% -$9.98M 3.33% 8
2015
Q3 		$606M Buy
8,167,274
+84,036
+1% +$6.02M 3.11% 8
2015
Q2 		$518M Sell
8,083,238
-73,066
-0.9% -$5.06M 2.47% 10
2015
Q1 		$630M Sell
8,156,304
-740,510
-8% -$57.6M 2.98% 9
2014
Q4 		$660M Sell
8,896,814
-1,497,348
-14% -$105M 3.36% 8
2014
Q3 		$612M Sell
10,394,162
-82,618
-0.8% -$5.22M 3.24% 8
2014
Q2 		$700M Sell
10,476,780
-28,518
-0.3% -$1.81M 3.73% 6
2014
Q1 		$638M Sell
10,505,298
-36,878
-0.3% -$2.2M 3.41% 7
2013
Q4 		$561M Sell
10,542,176
-146,168
-1% -$7.69M 3.12% 8
2013
Q3 		$533M Sell
10,688,344
-15,180
-0.1% -$730K 3.16% 7
2013
Q2 		$480M Buy
+10,703,524
New +$468M 3.09% 9

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's IDXX Position: Q4 2019 in Review

Ruane, Cunniff & Goldfarb sold out of Idexx Laboratories (IDXX) in Q4 2019, closing a stake of 1,146 shares — an estimated $312K sold.

Ruane, Cunniff & Goldfarb first reported a position in IDXX in Q2 2013 and held it in 26 quarters. The position peaked at $700M in Q2 2014. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

  • Ruane, Cunniff & Goldfarb reported no remaining Idexx Laboratories position as of Q4 2019 after selling out during the quarter.
  • Ruane, Cunniff & Goldfarb sold 1,146 Idexx Laboratories shares in Q4 2019, an estimated $312K.
  • Ruane, Cunniff & Goldfarb first reported a position in Idexx Laboratories in Q2 2013 and held it in 26 quarters.
  • Ruane, Cunniff & Goldfarb's Idexx Laboratories position peaked at $700M in Q2 2014.
  • 761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q4 2019, filed 14 Feb 2020.